Journal of the International Association of Providers of AIDS Care
-
J Int Assoc Provid AIDS Care · Mar 2015
Clinical TrialCost estimation of first-line antiretroviral therapy with zidovudine/stavudine as the nucleoside backbone in India: a pilot study.
In India, a zidovudine-based regimen is preferred as the first-line drug treatment for HIV, despite high rates of drug toxicity. This study estimates the treatment costs for HIV. ⋯ Current treatment is associated with toxicity, increasing treatment costs and imposing a significant economic burden.